Showing results (461-470 of 520) with videos related to

Sort By:
Pageof 52
Immunological Reviews|November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanomaPedro Romero, Danila Valmori, Mikael J Pittet, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Nature Genetics|June 2, 2025
Phylogenetic inference reveals clonal heterogeneity in circulating tumor cell clustersDavid Gremmelspacher, Johannes Gawron, Barbara M Szczerba, et al.
Journal for Immunotherapy of Cancer|July 14, 2026
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunityNicole Oelgarth, Kea Martin, Fabian Junker, et al.
Cell Reports. Medicine|March 25, 2021
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attackWeldy V Bonilla, Nicole Kirchhammer, Anna-Friederike Marx, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patientsDaniel E Speiser, Katrin Schwarz, Petra Baumgaertner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapyAbhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, et al.
Nature Immunology|October 6, 2020
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustionYi-Ru Yu, Hana Imrichova, Haiping Wang, et al.
Pageof 52